Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-11-23Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
-
CLINICAL_TRIALS study record update · 2021-11-18Response of Fatty Liver to Lifestyle Modification in Psoriasis Patients
-
CLINICAL_TRIALS study record update · 2021-11-12A Real-world Study of the Dietary Perceptions and Practices in Chinese Psoriasis Patients
-
CLINICAL_TRIALS study record update · 2021-11-09A Phase 1a/1b Randomized Double-blind Placebo-controlled Single and Multiple Ascending Dose Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
-
CLINICAL_TRIALS study record update · 2021-11-01Safety and Efficacy of Secukinumab in Adults With Chronic Plaque Type Psoriasis With a PASI Score of 6 to 12
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-10-21Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients
-
CLINICAL_TRIALS study record update · 2021-10-19The Role of Bacterial Toxins in Human Skin Disease
-
CLINICAL_TRIALS study record update · 2021-10-14Postmarketing Observational Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China
-
CLINICAL_TRIALS study record update · 2021-10-13A Phase Ⅱ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2021-10-12Effects of Weight-loss Treatment in Obese Patients With Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2021-10-12GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden
-
CLINICAL_TRIALS study record update · 2021-10-05A Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2021-10-01A Multi-center, Open-Label, Extension Study to Evaluate the Safety and Efficacy of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults
-
CLINICAL_TRIALS study record update · 2021-09-23Elucidating the Fundamental Differences Between HLA-Cw6 Positive and HLA-Cw6 Negative Psoriasis Skin Lesions, With a Comparison to Healthy Skin, at the Single Cell Level of the Infiltrated Immune Cell Types
-
CLINICAL_TRIALS study record update · 2021-09-16Combination of Breathing Exercises, Cold Exposure, and Meditation Mitigate Psoriasis - Open Label, Randomized, Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-09-13A Randomized, Double-blinded, Single-dose, 3-arms Parallel, Comparative Study to Evaluate the Pharmacokinetics and Safety of BAT2206 Injection vs Ustekinumab Injection (Stelara) in Healthy Chinese Male Subjects
-
CLINICAL_TRIALS study record update · 2021-09-10Systemic Treatment for Psoriasis Patients: A Prospective Multicentric Observational Cohort Study
-
CLINICAL_TRIALS study record update · 2021-09-08International Multi-center Comparative Randomized Double-blind Clinical Trial of Efficacy and Safety of BCD-057 (Adalimumab Produced by BIOCAD, Russia) and Humira® (Adalimumab Produced by Vetter Pharma-Fertigung Gmbh & Co KG, Germany) in Patients With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2021-08-30A Phase 1, Randomized, 3-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis.
-
CLINICAL_TRIALS study record update · 2021-08-27A PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-06826647 IN PARTICIPANTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
-
CLINICAL_TRIALS study record update · 2021-08-18Mindfulness-based Cognitive Therapy for Psoriasis Patients With Anxiety and Depression
-
CLINICAL_TRIALS study record update · 2021-08-16A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of JTE-451 Administered for 16 Weeks in Subjects With Moderate to Severe Plaque Psoriasis (IMPACT-PS)
-
CLINICAL_TRIALS study record update · 2021-08-02A Phase 2b Randomized, Double-blind, Placebo Controlled, Multi-center 12-week Study With an Additional 40-week Follow-up Assessment of Efficacy, Safety and Tolerability of M1095 in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
-
CLINICAL_TRIALS study record update · 2021-07-23SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
-
CLINICAL_TRIALS study record update · 2021-07-21The Efficacy and Safety of Topical Methotrexate Microemulsion in Combination With Excimer Light and Narrow Band-ultraviolet B in the Treatment of Plaque Psoriasis